What is the recommended dose of magnesium sulfate (MgSO4) for pediatric patients with acute asthma exacerbations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Magnesium Sulfate Dosing for Pediatric Asthma

For pediatric patients with severe asthma exacerbations not responding to conventional therapy, intravenous magnesium sulfate should be administered at a dose of 25-75 mg/kg (maximum 2-2.5 g) over 20 minutes. 1, 2

Indications for Use

Intravenous magnesium sulfate is recommended in the following scenarios:

  • Life-threatening asthma exacerbations
  • Severe exacerbations that remain severe after 1 hour of intensive conventional treatment
  • Not recommended for mild-to-moderate exacerbations 1

Dosing Considerations

  • The National Asthma Education and Prevention Program Expert Panel recommends selective use of IV magnesium sulfate in severe cases 1
  • Current evidence supports dosing between 25-75 mg/kg (maximum 2-2.5 g per dose) 2
  • A dose breakpoint analysis suggests caution with doses exceeding 27 mg/kg in children weighing less than 40 kg, as higher doses were associated with increased need for escalation in therapy 3

Administration Method

  • Traditional approach: Single infusion over 20 minutes 2
  • Alternative approach: Continuous infusion at 50 mg/kg/hour for 4 hours has shown to be well-tolerated with improved respiratory status in severe cases 4

Efficacy

Magnesium sulfate administration has demonstrated:

  • Significant improvement in pulmonary function parameters (FEV1, PEF, FEF25-75) in children with acute asthma 5
  • Earlier improvement in clinical signs and symptoms in patients not responding to conventional therapy 6
  • Reduced hospitalization rates in children with moderate to severe exacerbations 2

Monitoring

  • Target plasma concentration >4 mg/dL has been suggested as a surrogate marker of efficacy 2
  • Monitor vital signs and respiratory status during and after administration
  • Assess response through clinical parameters and pulmonary function tests when possible

Concurrent Therapy

Magnesium sulfate should be used as an adjunct to standard therapy, which includes:

  • Inhaled short-acting beta-agonists
  • Systemic corticosteroids
  • Ipratropium bromide
  • Oxygen as needed

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Escalation in Therapy Based on Intravenous Magnesium Sulfate Dosing in Pediatric Patients With Asthma Exacerbations.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2020

Research

Efficacy of Magnesium Sulfate Treatment in Children with Acute Asthma.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.